View Older Stories View More Recent Stories

Mar 9, 2023 04:15PM CytoSorbents Reports Fourth Quarter and Full Year 2022 Results
Mar 7, 2023 07:00AM New European “Guidelines for the Management of Severe Perioperative Bleeding” Consider Hemoadsorption for the First-Time
Mar 7, 2023 07:00AM New European “Guidelines for the Management of Severe Perioperative Bleeding” Consider Hemoadsorption for the First-Time
Feb 27, 2023 07:00AM CytoSorbents to Present at the Cowen 43rd Annual Health Care Conference
Feb 24, 2023 07:00AM CytoSorbents to Report Fiscal 2022 Operating and Financial Results
Jan 31, 2023 07:17AM Cytosorbents (CTSO) Issues Stockholder Letter, Reports Preliminary Fourth Quarter and Full Year 2022 Revenue
Jan 31, 2023 07:15AM CytoSorbents Issues Stockholder Letter and Reports Preliminary Fourth Quarter and Full Year 2022 Revenue
Jan 23, 2023 07:00AM CytoSorbents Announces Health Canada Regulatory Approval For Pivotal STAR-T Trial
Jan 17, 2023 07:00AM CytoSorbents Appoints Irina B. Kulinets, PhD, as Senior Vice President of Global Regulatory Affairs
Dec 29, 2022 07:02AM Cytosorbents (CTSO) Announces $5M in Non-Dilutive Debt Financing
Dec 29, 2022 07:00AM CytoSorbents Receives $5M in Non-Dilutive Debt Financing from Bridge Bank and Extends Loan Agreement
Dec 21, 2022 07:01AM Cytosorbents (CTSO) Announces DSMB's Recommendation to Continue STAR-T Trial As Planned Without Modifications
Dec 21, 2022 07:00AM CytoSorbents Receives Recommendation from Independent Data and Safety Monitoring Board to Continue Pivotal STAR-T Trial As Planned Without Modifications
Nov 14, 2022 07:00AM CytoSorbents Announces Pivotal STAR-T Trial Reaches First Milestone With 40 Patients Enrolled
Nov 3, 2022 04:15PM CytoSorbents Reports Third Quarter 2022 Financial and Operational Results
Nov 2, 2022 07:16AM Cytosorbents (CTSO) Announces CytoSorb and ECMO Achieves High Survival in 100 Critically Ill COVID-19 Patients
Nov 2, 2022 07:10AM 'Enhanced Lung Rest' with CytoSorb and ECMO Achieves High Survival in 100 Critically Ill COVID-19 Patients with Refractory Lung Failure from Five Major U.S. Hospitals
Oct 31, 2022 07:11AM Cytosorbents (CTSO) Announces National Institutes of Health Grants Phase I SBIR Award to it to Test Novel Polymers for Cytokine and Endotoxin Removal from Septic Porcine Plasma
Oct 31, 2022 07:00AM National Institutes of Health Grants Phase I SBIR Award to CytoSorbents to Test Novel Polymers for Cytokine and Endotoxin Removal from Septic Porcine Plasma
Oct 27, 2022 07:00AM CytoSorbents to Report Third Quarter 2022 Operating and Financial Results
Oct 12, 2022 07:01AM Cytosorbents (CTSO) Reports New Cardiac Surgery Data with CytoSorb
Oct 12, 2022 07:00AM CytoSorbents Reports New Cardiac Surgery Data with CytoSorb at the European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting
Oct 7, 2022 07:06AM Cytosorbents (CTSO) Announces Pending Retirement of Chief Financial Officer Kathleen P. Bloch
Oct 7, 2022 07:05AM CytoSorbents Announces Pending Retirement of Chief Financial Officer Kathleen P. Bloch
Oct 6, 2022 07:01AM Cytosorbents (CTSO) Awarded $4.3M Contract by the U.S. DoD to Develop HemoDefend-BGA
Oct 6, 2022 07:00AM CytoSorbents Awarded an Approximately $4.3M Contract by the U.S. Department of Defense to Develop HemoDefend-BGA™ for Freeze-Dried Universal Plasma
Oct 4, 2022 07:00AM CytoSorbents to Present at the Dawson James Securities 2022 Small Cap Growth Conference
Sep 27, 2022 08:23AM Cytosorbents (CTSO) Achieves ISO 13485 Certification of Princeton Manufacturing Facility in New Jersey
Sep 27, 2022 08:21AM CytoSorbents Achieves ISO 13485 Certification of Princeton Manufacturing Facility in New Jersey
Sep 9, 2022 07:02AM Cytosorbents (CTSO) Announces U.S. Department of Defense Awards it an Approximately $2.0M Contract to Support HemoDefend-BGA™ Development for Life-saving Universal Plasma
Sep 9, 2022 07:00AM The U.S. Department of Defense Awards CytoSorbents an Approximately $2.0M Contract to Support HemoDefend-BGA™ Development for Life-saving Universal Plasma
Sep 7, 2022 07:30AM CytoSorbents to Present at the H.C. Wainwright 24th Annual Global Investment Conference
Aug 23, 2022 07:04AM Cytosorbents' (CTSO) CytoSorb Granted National Reimbursement in Turkey
Aug 23, 2022 07:02AM Turkish Ministry of Health Grants National Reimbursement to CytoSorb®
Aug 17, 2022 07:03AM Cytosorbents (CTSO) Announces Israeli Approval of National Coverage for CytoSorb
Aug 17, 2022 07:02AM Israeli Ministry of Health Approves National Coverage for CytoSorb®
Aug 2, 2022 04:17PM CytoSorb® Becomes a Featured Blood Purification Therapy on Fresenius Medical Care Critical Care Platforms
Aug 2, 2022 04:15PM CytoSorbents Reports Second Quarter 2022 Financial and Operational Results
Jul 25, 2022 07:00AM CytoSorbents to Report Second Quarter 2022 Operating and Financial Results
Jul 8, 2022 08:44AM The 2022 CytoSorb World Users' Meeting Highlights the Broad Market Potential of CytoSorb as an Interdisciplinary Therapeutic Approach
Jul 1, 2022 07:00AM Leading Critical Care and Cardiac Surgery Specialists from 40 Countries Meet to Discuss CytoSorb and the New Dimension in Blood Purification
Jun 2, 2022 07:00AM CytoSorbents to Hold 2022 Annual Meeting of Stockholders Virtually
Jun 1, 2022 07:00AM CytoSorbents Partners with Nikkiso to Distribute the PureADJUST Hemoperfusion Blood Pump and Supplies in 14 Countries
May 19, 2022 07:00AM CytoSorbents to Present at Two Upcoming Investor Conferences
May 3, 2022 04:15PM CytoSorbents Reports First Quarter 2022 Results and Revises 2022 Outlook
May 2, 2022 07:03AM Cytosorbents (CTSO) Awarded Preferred Supplier Agreement with Asklepios
May 2, 2022 07:00AM CytoSorbents Awarded Preferred Supplier Agreement with Asklepios, One of the Largest Private Hospital Operators in Germany
Apr 29, 2022 07:00AM First Patient Enrolled in U.S. STAR-D Pivotal Trial Evaluating the DrugSorb™-ATR Antithrombotic Removal System to Remove Apixaban and Rivaroxaban During Cardiothoracic Surgery
Apr 28, 2022 07:00AM CytoSorbents Highlights the Strategy of "Enhanced Lung Rest" Using CytoSorb with ECMO to Help Treat Lung Failure at the 10th EuroELSO Congress
Apr 19, 2022 07:00AM CytoSorbents to Report First Quarter 2022 Operating and Financial Results
View More Recent Stories View Older Stories